ADOPTIVE IMMUNOTHERAPY WITH RECOMBINANT IL-2 AFTER AUTOLOGOUS BONE MARROW TRANSPLANTATION (ABMT) FOR HIGH RISK NEUROBLASTOMA (HR-NB)

Authors
Publication date
1 January 1996
Publisher
place:LONDRA

Abstract

IT IS DESCRIBED THE ROLE OF AN ADOPTIVE IMMUNOTHERAPY WITH RECOMBINANT IL-2 AFTER AUTOLOGOUS BONE MARROW TRANSPLANTATION (ABMT) FOR HIGH RISK NEUROBLASTOMA (HR-NB

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Archivio istituzionale della ricerca - Università di Modena e Reggio Emilia

    redirect
    oaioai:iris.unimore.it:11380/7471...
    Last time updated on 12/11/2016